HALEOSLABS — Haleos Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Haleos Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,497	3,156	3,060	3,447	3,338
Cost of Revenue
Gross Profit	976	946	1,024	1,334	1,360
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	3,256	2,976	2,898	3,147	3,046
Operating Profit	242	180	162	301	292
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	327	166	98.5	262	252
Provision for Income Taxes
Net Income After Taxes	253	114	63.3	187	178
Minority Interest
Net Income Before Extraordinary Items
Net Income	253	115	90.9	201	173
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	253	115	90.9	201	173
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	63.5	32.6	30.1	66.4	59.1
Dividends per Share